Epidemiology, Survival, and Second Primary Malignancies in T‐Cell Large Granular Lymphocytic Leukemia
Year: 2025
Type: article
Study design: Observational Study
Abstract: Introduction: Large granular lymphocytic leukemia (LGL) is a rare lymphoproliferative disorder, with limited literature available about the epidemiology, survival, and development of secondary primary malignancies (SPMs) in T-LGL. Methods: The Surveillance, Epidemiology, and End Results (SEER) 17 registry was used to identify all cases of T-LGL diagnosed between 2000 and 2019, and patients with primary T-LGL were analyzed. Results: Patients with primary T-LGL were found to have a higher incidence of SPMs compared to the general population, with increased risk for hematological malignancies seen within the first 10 years and solid tumors seen after 10 years of T-LGL diagnosis. Conclusion: Patients with primary T-LGL were found to have a higher incidence of SPMs. Further research is needed to better understand the reason for this increased risk. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
Source: eJHaem
DOI: 10.1002/jha2.70036
Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, The Ohio State University, Roswell Park Comprehensive Cancer Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,860
Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W4410129198
